期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌亚甲蓝示踪SLNB替代腋淋巴结清除术的初步研究报告 被引量：4

原文传递
导出
摘要 目的探讨乳腺癌前哨淋巴结活检术(SLNB)代替腋窝淋巴结清扫术(ALND)的可行性。方法对75例SLNB手术、病理诊断和随访结果进行分析。结果 75例患者行SLNB,67例(89.33%)成功。其中快速病理检查报告18例阳性,49例阴性;49例SLN阴性中术后HE染色病理证实2例(4.10%)有癌转移,再行ALND;平均随访45个月,仅1例前哨活检阴性患者术后15个月证实前哨位置淋巴结有癌转移。另46例至今未见复发。结论单一亚甲蓝示踪法SLNB准确性较高。对器材无特殊要求,学习曲线短。对于SLNB阴性患者,可不需行ALND。
作者 李东生 祝清华 孙思敬 路忠志 李敏 张丽丽
机构地区 山东省淄博市第一医院普外三科
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2011年第11期1276-1277,共2页 China Journal of General Surgery
关键词 乳腺肿瘤 前哨淋巴结活检 亚甲蓝
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1Torrenga H, Fabry H, van der Sijp JR, et al. Omitting axil- lary lymph node dissection in sentinel node negative breast cancer patients is safe : a long term follow-up analysis [ J ] . Journal of Surgical Oncology, 2004, 88 ( 1 ) :4 - 8.
  • 2Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary- lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial[J]. Lancet Oncol, 2007, 8(10) :881 - 888.
  • 3Low KS, Littlejohn DR. Optimal number of sentinel nodes after intradernal injection isotope and blue dye [ J ] . ANZ J Surg, 2006, 76(6) :472 -475.
  • 4徐鲲,刘晓安,王水,王振中.乳腺癌前哨淋巴结活检常用染料效果实验研究[J].现代肿瘤医学,2005,13(4):433-435. 被引量：2
  • 5Golshan M, Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast eaneer? [ J ]. The Breast Journal, 2006, 12(5) :428 -430.
  • 6Olson JA Jr, McCall LM, Beitsch P, et al. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Ontology Group Trials ZO010 and Z0011 [J]. J Clin Oncol, 2008, 26 (21) :3530 -3535.
  • 7Kim T, Giuliano AE, Lyman GH. Lymphatie mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis[ J ]. Cancer, 2006, 106(1) :4 - 16.
  • 8陈波,陆云飞,薛明兴,叶春梅,黄自明.乳腺癌前哨淋巴结活检对腋窝淋巴结状态的预测价值研究[J].中国普通外科杂志,2007,16(11):1115-1117. 被引量：4
  • 9Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate [ J ]. J Am Coil Surg, 2001, 192(6) :684 -689.
  • 10Kennedy R J, Koilias J, Gill PG, et al. Removal of two sentinel nodes accurately stages the axilla in breast cancer [ J ]. Br J Surg, 2003, 90(11) :1349 -1353.

二级参考文献15

  • 1付改发,汪存涛,宋养荣,雷光焰,宋张俊,付民,刘军良.前哨淋巴结活检对乳腺癌外科导航的临床分析[J].现代肿瘤医学,2004,12(3):203-204. 被引量：7
  • 2薛锋杰,姜建涛,王西京,代志军,薛兴欢,刘小旭,管海涛,康华峰.前哨淋巴结活检对乳腺癌腋窝淋巴结转移状况的预测价值[J].现代肿瘤医学,2004,12(5):425-426. 被引量：3
  • 3申郑堂,罗沙阳,王守满,邬玉辉,欧慧英,海健.乳腺癌哨兵淋巴结转移与肿瘤大小和癌基因及激素受体表达关系的临床观察[J].中国普通外科杂志,2006,15(10):728-731. 被引量：10
  • 4Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model[ J]. Ann Surg, 1991,214:637 ～641.
  • 5Lucci A, Turner RR, Morton DL, et al. Carbon dye as an adjunct to isosulfan blue dye for sentinel lymph node dissection[J]. Surg,1999,126:48 ～ 53.
  • 6Simmons R, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization [ J ]. Ann Surg Oncol, 2003,10 ( 3 ) :242 ～ 247.
  • 7Veronesi U, Paganelli G, Galimberti V, et al. Sentinel- node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes [ J ]. Lancet, 1997, 349 (9069) :1864-1867.
  • 8Morton DL, Wen DR, Foshag LJ, et al. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol, 1993,11(9) :1751 - 1756.
  • 9Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994,220(3) :391 -398.
  • 10Giuliano AE, Jones RC, Brenan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol, 1997,15:2345 - 2350.

共引文献4

同被引文献56

  • 1张凌,闫彩芸,姚力.难治性继发性甲状旁腺功能亢进症的外科治疗[J].中国血液净化,2012,11(7):349-351. 被引量：17
  • 2吴炅,沈镇宙.乳腺癌前哨淋巴结的研究现状与评价[J].中国癌症杂志,2005,15(5):417-421. 被引量：12
  • 3杨光伦,厉红元.90例乳晕下及肿瘤周围注射法定位乳腺癌前哨淋巴结的对比分析[J].重庆医学,2005,34(12):1785-1786. 被引量：3
  • 4Land SR, Kopee JA, Julian TB, et al. Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvanl Breast and Bowvel Project phase III protocol B-32[J]. J Clin Oneol, 2010, 28(25):3929-3936.
  • 5Behnonte R, Garin O, Segura M, et al. Quality-of-life impact of sentinel lymph node biopsy versus axillary lymph node disseetion in breast cancer patients[J]. Value Health, 2012, 15(6):907-915.
  • 6Banerjee M, George J, Song EY, et al. Tree-based model for breast eancer prognostication[J]. J Clin Oncol, 2004, 22(13):2567-2575.
  • 7Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total maslectomy, and total mastectomy followed by irradiation[J]. N Engl J Med, 2002, 347(8):567-575.
  • 8Nesvold II, Dahl AA, Lokkevik E, et al. Arm and shoulder morbidity in breast cancer patienls after breasl-conserving therapy versus masleclamy[J] Aeta Oncol, 2008, 47(5):835-842.
  • 9Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall smwival findings from the NSABP B-32 randomised phase 3 I rial[J]. Lancet Oncol, 2010, 11 ( 10):927-933.
  • 10Galimberti V, Cole BF, Zurrida S, el al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial[J]. Lancet Oncol, 2013, 14(4):297-305.

引证文献4

二级引证文献23

中国普通外科杂志
2011年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部